ReviewCurrent obesity reports2023

GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use.

Konstantinos Arvanitakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.